Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China.
J Cancer Res Ther. 2022 Apr;18(2):384-390. doi: 10.4103/jcrt.jcrt_1659_21.
To evaluate the safety and effectiveness of open superconducting magnetic resonance (MR)-guided microwave ablation of liver tumors and explore feasibility of real-time imaging sequence-guided needle insertion technique.
Medical records of December 2019-May 2021 of microwave ablations of liver tumors under MR guidance in XX University Cancer Center were reviewed. Real-time imaging-guided puncture technique refers to real-time insertion and adjusting the position of a microwave applicator under a fast imaging sequence. The safety and efficacy of the procedure among the enrolled patients were assessed.
Twenty-six patients underwent 27 procedures, with 30 lesions ablated (long diameter: 1.51 ± 0.81 cm, short diameter: 1.30 ± 0.61 cm). There were 20 cases of primary liver cancer and 10 of liver metastases. All lesions were identified by MR imaging (MRI), and all procedures were successfully performed using the finger positioning method for puncture sites. Five patients underwent real-time guided needle insertion techniques. Further, the microwave applicators reached the target position at once, and the entire insertion process was completed within 3 min. The completion rate of the real-time guided needle insertion technology was 100%, and 25 (92.6%) patients had minor complications. No severe complications were observed, and the technical success rate of 30 MRI-guided lesions was 100%. Finally, the complete ablation rate of the MRI-guided ablation after the first procedure was 93.1%.
Open MR-guided microwave ablation is safe and effective in treating liver tumors. Furthermore, real-time imaging sequence-guided puncture technique under MRI is feasible and efficient.
评估开放式超导磁共振(MR)引导下微波消融肝脏肿瘤的安全性和有效性,并探讨实时成像序列引导下的针插入技术的可行性。
回顾了 2019 年 12 月至 2021 年 5 月在 XX 大学癌症中心接受 MR 引导下微波消融肝脏肿瘤的患者的病历。实时成像引导下的穿刺技术是指在快速成像序列下实时插入和调整微波辐射器的位置。评估了入组患者的手术安全性和疗效。
26 例患者共进行了 27 次手术,消融了 30 个病灶(长径:1.51±0.81cm,短径:1.30±0.61cm)。其中原发性肝癌 20 例,肝转移癌 10 例。所有病灶均通过磁共振成像(MRI)识别,所有操作均采用手指定位法进行穿刺部位。5 例患者采用实时引导针插入技术。进一步地,微波辐射器立即到达目标位置,整个插入过程在 3 分钟内完成。实时引导针插入技术的完成率为 100%,25 例(92.6%)患者出现轻微并发症。未观察到严重并发症,30 例 MRI 引导下病变的技术成功率为 100%。最后,首次治疗后 MRI 引导下消融的完全消融率为 93.1%。
开放式 MR 引导下微波消融治疗肝脏肿瘤是安全有效的。此外,MRI 下实时成像序列引导下的穿刺技术是可行且高效的。